Assessing CAR T response with patient-derived glioblastoma organoids | Webinar | Dr. Meghan Logun

Assessing CAR T response with patient-derived glioblastoma organoids | Webinar | Dr. Meghan Logun

Dr Lisa Ebert - Developing a new CAR-T cell therapy for glioblastomaПодробнее

Dr Lisa Ebert - Developing a new CAR-T cell therapy for glioblastoma

Car-T Cells for Brain Tumors, by Lisa Feldman, MD, PhDПодробнее

Car-T Cells for Brain Tumors, by Lisa Feldman, MD, PhD

Adoptive cell therapy for solid malignanciesПодробнее

Adoptive cell therapy for solid malignancies

Brain tumor organoids accurately model patient response to CAR T cell therapyПодробнее

Brain tumor organoids accurately model patient response to CAR T cell therapy

Revolutionizing the monitoring of CAR T cell therapies against solid tumors with the 3D imagingПодробнее

Revolutionizing the monitoring of CAR T cell therapies against solid tumors with the 3D imaging

Glioblastoma CAR-T TherapyПодробнее

Glioblastoma CAR-T Therapy

Intraventricular CARv3-TEAM-E T Cells in Recurrent GlioblastomaПодробнее

Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma

Cancer treatment immunotherapy: Targeting glioblastoma with T cellsПодробнее

Cancer treatment immunotherapy: Targeting glioblastoma with T cells

CAR T-cell Cytotoxicity of Solid Tumors is Dependent on IFNγR Signaling & Downstream AdhesionПодробнее

CAR T-cell Cytotoxicity of Solid Tumors is Dependent on IFNγR Signaling & Downstream Adhesion

Dr. Shaughnessy on the Emergence of CAR T-Cell Therapy in Hematologic MalignanciesПодробнее

Dr. Shaughnessy on the Emergence of CAR T-Cell Therapy in Hematologic Malignancies

How to identify and mitigate neurologic AEs when treating with CAR-T and T-cell engagers?Подробнее

How to identify and mitigate neurologic AEs when treating with CAR-T and T-cell engagers?

Dr. Adusumilli on the Development of CAR T Cells in Solid TumorsПодробнее

Dr. Adusumilli on the Development of CAR T Cells in Solid Tumors

Spatial proteomic analysis of CAR T cells in solid tumorПодробнее

Spatial proteomic analysis of CAR T cells in solid tumor

CAR T cellsПодробнее

CAR T cells

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell TherapyПодробнее

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

Kinetics and potency of GD2 CAR-T Cell-mediated cytolysis of glioblastomaПодробнее

Kinetics and potency of GD2 CAR-T Cell-mediated cytolysis of glioblastoma

Retinoblastoma Questions & Answers – Clinical and research experts SJD Barcelona Children's HospitalПодробнее

Retinoblastoma Questions & Answers – Clinical and research experts SJD Barcelona Children's Hospital

Challenges with implementing CAR-T approaches in solid tumorsПодробнее

Challenges with implementing CAR-T approaches in solid tumors